The tryptophan metabolic pathway of the microbiome and host cells in health and disease
International Immunology · 14.11.2024 · 36 (12) · 601-616
DOI: 10.1093/intimm/dxae035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 13.06.2024. Verfasst von Kentaro Miyamoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Tryptophan, Microbiota. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The intricate and dynamic tryptophan (Trp) metabolic pathway in both the microbiome and host cells highlights its profound implications for health and disease. This pathway involves complex interactions between host cellular and bacteria processes, producing bioactive compounds such as 5-hydroxytryptamine (5-HT) and kynurenine derivatives. Immune responses to Trp metabolites through specific receptors have been explored, highlighting the role of the aryl hydrocarbon receptor in inflammation modulation. Dysregulation of this pathway is implicated in various diseases, such as Alzheimer’s and Parkinson’s diseases, mood disorders, neuronal diseases, autoimmune diseases such as multiple sclerosis (MS), and cancer. In this article, we describe the impact of the 5-HT, Trp, indole, and Trp metabolites on health and disease. Furthermore, we review the impact of microbiome-derived Trp metabolites that affect immune responses and contribute to maintaining homeostasis, especially in an experimental autoimmune encephalitis model of MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- Miyarisan Pharmaceutical Co., Research Laboratory, Tokyo, Japan.
- Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
- Keio Global Research Institute, Keio University, Tokyo, Japan.
ORCID-Profile: Tomohisa Sujino
Förderung
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
Zitieren
APA
Miyamoto, K., Sujino, T., & Kanai, T. (2024). The tryptophan metabolic pathway of the microbiome and host cells in health and disease. International Immunology, 36(12), 601-616. https://doi.org/10.1093/intimm/dxae035
Vancouver
Miyamoto K, Sujino T, Kanai T. The tryptophan metabolic pathway of the microbiome and host cells in health and disease. International Immunology. 2024;36(12):601-616. doi:10.1093/intimm/dxae035
BibTeX
@article{Miyamoto2024,
author = {Miyamoto, Kentaro and Sujino, Tomohisa and Kanai, Takanori},
title = {The tryptophan metabolic pathway of the microbiome and host cells in health and disease},
journal = {International Immunology},
year = {2024},
volume = {36},
number = {12},
pages = {601--616},
doi = {10.1093/intimm/dxae035}
}
EUVIMED